No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d3dyaB_, 1.0000, 0.00, 1.000, 402, 402, HIV-1 RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 1
2, d3ffiB_, 0.9978, 0.34, 1.000, 403, 402, HIV-1 RT WITH PYRIDONE NON-NUCLEOSIDE INHIBITOR
3, d3e01B_, 0.9953, 0.34, 1.000, 401, 401, HIV-RT WITH NON-NUCLEOSIDE INHIBITOR ANNULATED PYRAZOLE 2
4, d3m8pB_, 0.9946, 0.39, 1.000, 401, 401, HIV-1 RT WITH NNRTI TMC-125
5, d2yniB_, 0.9944, 0.55, 1.000, 404, 402, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK952
6, d4kv8B_, 0.9943, 0.65, 0.998, 407, 402, CRYSTAL STRUCTURE OF HIV RT IN COMPLEX WITH BILR0355BS
7, d2yngB_, 0.9941, 0.56, 1.000, 411, 402, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK560
8, d2ynhB_, 0.9931, 0.61, 1.000, 406, 402, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR GSK500
9, d3nbpB_, 0.9901, 0.35, 1.000, 400, 399, HIV-1 REVERSE TRANSCRIPTASE WITH AMINOPYRIMIDINE INHIBITOR 2
10, d3tamB_, 0.9897, 0.65, 0.997, 403, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M06
11, d4i7fB_, 0.9889, 0.45, 1.000, 405, 399, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A PHOSPHONATE ANALOG OF NEVIRAPINE
12, d2ynfB_, 0.9888, 0.69, 1.000, 406, 401, HIV-1 REVERSE TRANSCRIPTASE Y188L MUTANT IN COMPLEX WITH INHIBITOR GSK560
13, d3m8qB_, 0.9884, 0.29, 1.000, 398, 398, HIV-1 RT WITH AMINOPYRIMIDINE NNRTI
14, d3di6B_, 0.9884, 0.70, 0.997, 400, 399, HIV-1 RT WITH PYRIDAZINONE NON-NUCLEOSIDE INHIBITOR
15, d3drsB_, 0.9881, 0.71, 0.997, 405, 400, HIV REVERSE TRANSCRIPTASE K103N MUTANT IN COMPLEX WITH INHIBITOR R8D
16, d3i0sB_, 0.9877, 0.74, 1.000, 405, 400, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7
17, d4ncgB_, 0.9872, 0.40, 1.000, 402, 398, DISCOVERY OF DORAVIRINE AN ORALLY BIOAVAILABLE NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR POTENT AGAINST A WIDE RANGE OF RESISTANT MUTANT HIV VIRUSES
18, d2jleB_, 0.9870, 0.93, 0.998, 415, 401, NOVEL INDAZOLE NNRTIS CREATED USING MOLECULAR TEMPLATE HYBRIDIZATION BASED ON CRYSTALLOGRAPHIC OVERLAYS
19, d3drpB_, 0.9866, 0.68, 1.000, 404, 399, HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR R8E
20, d3i0rB_, 0.9865, 0.76, 1.000, 405, 400, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 3
21, d3c6tB_, 0.9864, 0.68, 1.000, 404, 399, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 14
22, d2rkiB_, 0.9861, 0.48, 1.000, 402, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A TRIAZOLE DERIVED NNRTI
23, d3mecB_, 0.9858, 0.48, 1.000, 401, 398, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
24, d3c6uB_, 0.9858, 0.72, 1.000, 404, 399, CRYSTAL STRUCTURE OF HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 22
25, d5k14B_, 0.9855, 0.51, 1.000, 401, 398, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 26-DIFLUOROPHENYL DAPY ANALOG
26, d3t1aB_, 0.9854, 0.61, 0.997, 400, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N MUTANT) IN COMPLEX WITH INHIBITOR M05
27, d3medB_, 0.9854, 0.51, 0.997, 401, 398, HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC125
28, d3meeB_, 0.9851, 0.52, 1.000, 401, 398, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
29, d3qipB_, 0.9848, 0.54, 1.000, 402, 398, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH AN RNASE H INHIBITOR AND NEVIRAPINE
30, d3drrB_, 0.9847, 0.76, 0.997, 404, 399, HIV REVERSE TRANSCRIPTASE Y181C MUTANT IN COMPLEX WITH INHIBITOR R8E
31, d3t19B_, 0.9846, 0.65, 0.997, 400, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (WILD TYPE) IN COMPLEX WITH INHIBITOR M05
32, d3megB_, 0.9846, 0.54, 0.997, 404, 398, HIV-1 K103N REVERSE TRANSCRIPTASE IN COMPLEX WITH TMC278
33, d2rf2B_, 0.9838, 0.87, 1.000, 405, 400, HIV REVERSE TRANSCRIPTASE IN COMPLEX WITH INHIBITOR 7E (NNRTI)
34, d1ikxB_, 0.9837, 1.14, 0.973, 427, 401, K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR PNU142721
35, d3lp2B_, 0.9836, 0.69, 0.997, 400, 398, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
36, d2wonB_, 0.9824, 0.88, 0.992, 412, 398, CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (WILD-TYPE).
37, d3lp1B_, 0.9822, 0.75, 0.997, 400, 398, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
38, d3lp0B_, 0.9816, 0.76, 0.997, 400, 398, HIV-1 REVERSE TRANSCRIPTASE WITH INHIBITOR
39, d1ikyB_, 0.9806, 0.92, 0.980, 405, 399, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC194
40, d1ikwB_, 0.9805, 0.92, 0.982, 405, 399, WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFAVIRENZ
41, d2vg5B_, 0.9783, 0.92, 0.995, 401, 397, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
42, d2yknB_, 0.9775, 1.11, 0.990, 410, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
43, d1ikvB_, 0.9774, 0.93, 0.982, 404, 398, K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH EFIVARENZ
44, d2ykmB_, 0.9759, 1.16, 0.990, 410, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
45, d2vg6B_, 0.9730, 1.13, 0.995, 401, 397, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
46, d1eetB_, 0.9730, 1.07, 0.982, 399, 396, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204
47, d5hbmB_, 0.9713, 1.37, 0.978, 413, 402, CRYSTAL STRUCTURE OF A DIHYDROXYCOUMARIN RNASE H ACTIVE-SITE INHIBITOR IN COMPLEX WITH HIV-1 REVERSE TRANSCRIPTASE
48, d4h4mB_, 0.9712, 1.44, 0.985, 428, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)- YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
49, d1s9gB_, 0.9710, 1.38, 0.970, 425, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R120394.
50, d4lslB_, 0.9708, 1.28, 0.985, 417, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-(4-CHLORO-2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)PHENYL)ACRYLONITRILE (JLJ476) A NON-NUCLEOSIDE INHIBITOR
51, d1tv6B1, 0.9705, 1.18, 0.990, 411, 399, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94707
52, d4h4oB_, 0.9703, 1.47, 0.985, 428, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH (E)-3-(3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)- 4- FLUOROPHENOXY)-5-FLUOROPHENYL)ACRYLONITRILE (JLJ506) A NON- NUCLEOSIDE INHIBITOR
53, d1s9eB_, 0.9698, 1.44, 0.985, 427, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R129385
54, d4mfbB_, 0.9696, 1.36, 0.985, 413, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 8-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY) INDOLIZINE-2-CARBONITRILE (JLJ555) A NON-NUCLEOSIDE INHIBITOR
55, d2i5jB_, 0.9696, 1.27, 0.982, 420, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH DHBNH AN RNASE H INHIBITOR
56, d2be2B_, 0.9695, 1.48, 0.973, 426, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH R221239
57, d2b5jB_, 0.9693, 1.28, 0.975, 427, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165481
58, d2banB_, 0.9689, 1.43, 0.978, 427, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R157208
59, d1suqB_, 0.9687, 1.44, 0.985, 427, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R185545
60, d2vg7B_, 0.9685, 1.01, 0.992, 395, 394, CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS
61, d1rtdB_, 0.9679, 1.26, 0.992, 414, 400, STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
62, d1s6qB_, 0.9678, 1.32, 0.985, 427, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R147681
63, d1sv5B_, 0.9673, 1.40, 0.973, 427, 401, CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R165335
64, d4lsnB_, 0.9669, 1.39, 0.983, 416, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-BROMO-5-(4-CHLORO-2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)- YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ518) A NON-NUCLEOSIDE INHIBITOR
65, d4pwdD_, 0.9668, 1.27, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BULGE-RNA/DNA AND NEVIRAPINE
66, d5tw3B_, 0.9665, 1.23, 0.985, 409, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)-4-FLUOROPHENOXY)- 7-FLUORO-2-NAPHTHONITRILE (JLJ636) A NON-NUCLEOSIDE INHIBITOR
67, d4pwdB_, 0.9663, 1.29, 0.992, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BULGE-RNA/DNA AND NEVIRAPINE
68, d1t05B_, 0.9663, 1.29, 0.987, 414, 400, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE-PRIMER WITH TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMING NUCLEOTIDE SUBSTRATE
69, d5tepB_, 0.9656, 1.25, 0.985, 407, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 7-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-2- NAPHTHONITRILE (JLJ649) A NON-NUCLEOSIDE INHIBITOR
70, d4rw8B_, 0.9655, 1.20, 0.985, 415, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH (E)- 3-(3-CHLORO-5-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON-NUCLEOSIDE INHIBITOR 
71, d2b6aB_, 0.9653, 1.47, 0.988, 427, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THR-50
72, d1s6pB_, 0.9652, 1.51, 0.978, 427, 401, CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN-R100943
73, d5fdlB_, 0.9651, 0.67, 0.990, 396, 391, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH IDX899
74, d4o44B_, 0.9650, 1.48, 0.983, 427, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-(MESITYLAMINO)-6-(3-MORPHOLINOPROPOXY)-135-TRIAZIN-2-YL)AMINO) BENZONITRILE (JLJ529) A NON-NUCLEOSIDE INHIBITOR
75, d1hquB_, 0.9650, 1.61, 0.975, 430, 402, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
76, d4puoD_, 0.9648, 1.32, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND NEVIRAPINE
77, d1rtdD_, 0.9641, 1.35, 0.995, 414, 400, STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE
78, d1s1wB1, 0.9638, 1.41, 0.975, 404, 399, CRYSTAL STRUCTURE OF V106A MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
79, d1hpzB_, 0.9637, 1.64, 0.978, 430, 402, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
80, d4puoB_, 0.9630, 1.37, 0.987, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND NEVIRAPINE
81, d1hniB_, 0.9629, 1.55, 0.973, 427, 401, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN A COMPLEX WITH THE NONNUCLEOSIDE INHIBITOR ALPHA-APA R 95845 AT 2.8 ANGSTROMS RESOLUTION
82, d1hnvB_, 0.9627, 1.53, 0.970, 427, 401, STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS
83, d1bqmB_, 0.9627, 1.60, 0.973, 430, 402, HIV-1 RT/HBY 097
84, d1uwbB_, 0.9623, 1.54, 0.968, 427, 401, TYR 181 CYS HIV-1 RT/8-CL TIBO
85, d1tvrB_, 0.9621, 1.54, 0.980, 427, 401, HIV-1 RT/9-CL TIBO
86, d1bqnB_, 0.9607, 1.63, 0.965, 430, 402, TYR 188 LEU HIV-1 RT/HBY 097
87, d1vruB_, 0.9603, 1.64, 0.992, 410, 400, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
88, d4pquB_, 0.9601, 1.38, 0.977, 412, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND DATP
89, d1revB_, 0.9600, 1.65, 1.000, 412, 400, HIV-1 REVERSE TRANSCRIPTASE
90, d1fk9B_, 0.9599, 1.31, 0.985, 403, 396, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP- 266(EFAVIRENZ)
91, d4dg1B_, 0.9590, 1.53, 0.970, 418, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH POLYMORPHISM MUTATION K172A AND K173A
92, d1vrtB_, 0.9586, 1.40, 0.990, 401, 397, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
93, d2ze2B_, 0.9582, 1.69, 0.988, 416, 401, CRYSTAL STRUCTURE OF L100I/K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
94, d3ithB_, 0.9581, 1.42, 0.950, 415, 398, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
95, d1lwcB_, 0.9577, 1.37, 0.975, 402, 396, CRYSTAL STRUCTURE OF M184V MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
96, d1dtqB_, 0.9572, 1.54, 1.000, 402, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT- 1 (PETT131A94)
97, d4o4gB_, 0.9570, 1.72, 0.988, 428, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-(MESITYLAMINO)-135-TRIAZIN-2-YL)AMINO)BENZONITRILE (JLJ527) A NON-NUCLEOSIDE INHIBITOR
98, d3bgrB_, 0.9567, 1.79, 0.990, 412, 401, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
99, d4i2pB_, 0.9564, 1.66, 0.990, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) BASED ANALOGUE
100, d3kk2B_, 0.9563, 1.62, 0.993, 414, 401, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH DATP BOUND IN THE NUCLEOTIDE BINDING SITE
101, d1rtjB1, 0.9560, 1.61, 0.997, 417, 400, MECHANISM OF INHIBITION OF HIV-1 REVERSE TRANSCRIPTASE BY NON-NUCLEOSIDE INHIBITORS
102, d1dttB_, 0.9560, 1.36, 0.995, 412, 397, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT- 2 (PETT130A94)
103, d3dlkB_, 0.9558, 1.45, 0.982, 409, 397, CRYSTAL STRUCTURE OF AN ENGINEERED FORM OF THE HIV-1 REVERSE TRANSCRIPTASE RT69A
104, d4i2qB_, 0.9557, 1.81, 0.988, 416, 401, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RILPIVIRINE (TMC278) ANALOGUE
105, d1lw2B_, 0.9555, 1.36, 0.970, 406, 395, CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 1051U91
106, d2oppB_, 0.9549, 1.38, 0.977, 403, 395, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
107, d1r0aB1, 0.9549, 1.72, 0.975, 429, 402, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS
108, d1s1uB1, 0.9547, 1.38, 0.975, 401, 395, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
109, d3kk1B_, 0.9545, 1.60, 0.995, 412, 400, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH NUCEOTIDE INHIBITOR GS- 9148-DIPHOSPHATE BOUND IN NUCLEOTIDE SITE
110, d2ic3B_, 0.9545, 1.71, 0.967, 427, 400, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH NONNUCLEOSIDE INHIBITOR HBY 097
111, d4kkoB_, 0.9544, 1.81, 0.990, 412, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 4- ((4-METHOXY-6-(2-MORPHOLINOETHOXY)-135-TRIAZIN-2-YL)AMINO)-2-((3- METHYLBUT-2-EN-1-YL)OXY)BENZONITRILE (JLJ513) A NON-NUCLEOSIDE INHIBITOR
112, d4g1qB_, 0.9544, 1.71, 0.987, 416, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE (TMC278 EDURANT) A NON-NUCLEOSIDE RT-INHIBITING DRUG
113, d4ig0B_, 0.9543, 1.82, 0.988, 416, 401, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 507 SITE
114, d5c24B_, 0.9542, 1.71, 0.990, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 7- ((4-((4-CYANOPHENYL)AMINO)-135-TRIAZIN-2-YL)AMINO)-68- DIMETHYLINDOLIZINE-2-CARBONITRILE (JLJ605) A NON-NUCLEOSIDE INHIBITOR
115, d1n6qB_, 0.9540, 1.73, 0.985, 429, 402, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
116, d2opqB_, 0.9537, 1.35, 0.977, 400, 394, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
117, d4iclB_, 0.9533, 1.76, 0.987, 412, 400, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE INCOMING DNTP BINDING SITE
118, d5cyqB_, 0.9532, 1.73, 0.987, 415, 400, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-BROMOPYRAZOLE
119, d2hnyB_, 0.9531, 1.36, 0.972, 401, 394, CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
120, d3ig1B_, 0.9530, 1.45, 0.980, 409, 396, HIV-1 REVERSE TRANSCRIPTASE WITH THE INHIBITOR BETA- THUJAPLICINOL BOUND AT THE RNASE H ACTIVE SITE
121, d3ithD_, 0.9529, 1.63, 0.977, 415, 399, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
122, d1tl3B1, 0.9528, 1.31, 0.980, 400, 393, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW450557
123, d1tktB1, 0.9526, 1.32, 0.977, 399, 393, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW426318
124, d1tl1B1, 0.9524, 1.32, 0.980, 397, 393, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW451211
125, d1rt3B_, 0.9524, 1.26, 0.990, 398, 393, AZT DRUG RESISTANT HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 1051U91
126, d1n5yB_, 0.9524, 1.76, 0.985, 429, 402, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
127, d1tkzB1, 0.9522, 1.32, 0.980, 400, 393, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW429576
128, d1lw0B_, 0.9522, 1.33, 0.980, 399, 393, CRYSTAL STRUCTURE OF T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
129, d3qlhB_, 0.9521, 1.62, 0.970, 407, 397, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH MANICOL AT THE RNASE H ACTIVE SITE AND TMC278 (RILPIVIRINE) AT THE NNRTI BINDING POCKET
130, d1t03B_, 0.9520, 1.77, 0.978, 429, 402, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P)
131, d4we1B_, 0.9519, 1.16, 0.982, 402, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5-(2- (2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-2- NAPHTHONITRILE (JLJ600)
132, d4ifvB_, 0.9518, 1.77, 0.990, 412, 400, DETECTING ALLOSTERIC SITES OF HIV-1 REVERSE TRANSCRIPTASE BY X-RAY CRYSTALLOGRAPHIC FRAGMENT SCREENING
133, d1fkoB_, 0.9518, 1.17, 0.987, 403, 392, CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
134, d4ig3B_, 0.9515, 1.77, 0.987, 416, 400, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT NEAR KNUCKLES SITE
135, d4idkB_, 0.9514, 1.78, 0.987, 412, 400, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE 428 SITE
136, d4ifyB_, 0.9513, 1.77, 0.990, 412, 400, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE KNUCKLES SITE
137, d4pquD_, 0.9511, 1.58, 0.982, 413, 399, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH RNA/DNA AND DATP
138, d2hnzB_, 0.9510, 1.34, 0.975, 399, 393, CRYSTAL STRUCTURE OF E138K MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
139, d4id5B_, 0.9507, 1.80, 0.987, 412, 400, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT THE RNASE H PRIMER GRIP SITE
140, d3is9B_, 0.9506, 1.87, 0.988, 416, 401, CRYSTAL STRUCTURE OF THE HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE ALKENYLDIARYLMETHANE (ADAM) NON-NUCLEOSIDE RT INHIBITOR DIMETHYL 33 -(6-METHOXY-6-OXOHEX-1-ENE-11- DIYL)BIS(5-CYANO-6-METHOXYBENZOATE).
141, d1c1cB_, 0.9504, 1.37, 0.987, 416, 395, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK- 6123
142, d3kliB_, 0.9499, 1.66, 0.952, 427, 399, CRYSTAL STRUCTURE OF UNLIGANDED AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE
143, d2zd1B_, 0.9499, 1.78, 0.990, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TMC278 (RILPIVIRINE) A NON-NUCLEOSIDE RT INHIBITOR
144, d1c1bB_, 0.9499, 1.44, 0.982, 415, 396, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GCA- 186
145, d3kk3B_, 0.9494, 1.53, 0.990, 407, 398, HIV-1 REVERSE TRANSCRIPTASE-DNA COMPLEX WITH GS-9148 TERMINATED PRIMER
146, d4zhrB_, 0.9491, 1.42, 0.972, 409, 395, STRUCTURE OF HIV-1 RT Q151M MUTANT
147, d1rthB1, 0.9491, 1.56, 0.990, 413, 397, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
148, d4kfbB_, 0.9486, 1.83, 0.987, 412, 400, HIV-1 REVERSE TRANSCRIPTASE WITH BOUND FRAGMENT AT NNRTI ADJACENT SITE
149, d4i7gB_, 0.9485, 1.83, 0.987, 412, 400,  
150, d3isnD_, 0.9479, 1.71, 0.975, 415, 399, CRYSTAL STRUCTURE OF HIV-1 RT BOUND TO A 6-VINYLPYRIMIDINE INHIBITOR
151, d1s1tB_, 0.9477, 1.38, 0.985, 416, 394, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
152, d1dloB_, 0.9475, 1.69, 0.947, 415, 398, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
153, d3qo9B_, 0.9474, 1.95, 0.970, 412, 400, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TSAO-T A NON-NUCLEOSIDE RT INHIBITOR (NNRTI)
154, d5tuqB_, 0.9469, 1.47, 0.980, 405, 394, CRYSTAL STRUCTURE OF A 6-CYCLOHEXYLMETHYL-3-HYDROXYPYRIMIDINE-24- DIONE INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
155, d5vqsB_, 0.9468, 1.35, 0.972, 403, 393, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)ACRYLAMIDE (JLJ685) A NON- NUCLEOSIDE INHIBITOR
156, d5c25B_, 0.9468, 1.53, 0.985, 406, 395, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 6- ((4-((4-CYANOPHENYL)AMINO)-135-TRIAZIN-2-YL)AMINO)-57-DIMETHYL-2- NAPHTHONITRILE (JLJ639) A NON-NUCLEOSIDE INHIBITOR
157, d4rw4B_, 0.9468, 1.64, 0.992, 405, 396, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103NY181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
158, d1qe1B_, 0.9468, 1.71, 0.945, 415, 398, CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV-1 REVERSE TRANSCRIPTASE
159, d2iajB_, 0.9467, 1.69, 0.962, 415, 398, CRYSTAL STRUCTURE OF K103N/Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH ATP
160, d1rtiB1, 0.9467, 1.36, 0.990, 407, 393, HIGH RESOLUTION STRUCTURES OF HIV-1 RT FROM FOUR RT- INHIBITOR COMPLEXES
161, d1jlbB_, 0.9466, 1.35, 0.987, 405, 393, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
162, d2hndB_, 0.9458, 1.24, 0.979, 394, 390, CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
163, d1rt7B1, 0.9455, 1.43, 0.987, 406, 394, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC84
164, d1c0uB_, 0.9453, 1.38, 0.990, 414, 393, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+50.0934
165, d1rt6B1, 0.9452, 1.38, 0.985, 405, 393, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC38
166, d1hvuK_, 0.9452, 1.22, 0.956, 400, 390, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
167, d1hvuH_, 0.9452, 1.22, 0.956, 400, 390, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
168, d1hvuE_, 0.9452, 1.22, 0.956, 400, 390, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
169, d1hvuB_, 0.9452, 1.22, 0.956, 400, 390, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED WITH A 33-BASE NUCLEOTIDE RNA PSEUDOKNOT
170, d1jlqB_, 0.9451, 1.52, 0.987, 405, 394, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 739W94
171, d1jleB_, 0.9451, 1.33, 0.987, 408, 392, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE
172, d4rw7B_, 0.9449, 1.67, 0.992, 405, 396, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON-NUCLEOSIDE INHIBITOR
173, d3dokB_, 0.9448, 1.33, 0.985, 402, 392, CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW678248.
174, d3irxB_, 0.9447, 1.99, 0.988, 416, 401, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH THE NON-NUCLEOSIDE RT INHIBITOR (E)-S-METHYL 5-(1-(37-DIMETHYL-2-OXO-23-DIHYDROBENZO[D]OXAZOL-5-YL)-5- (5-METHYL-134-OXADIAZOL-2-YL)PENT-1-ENYL)-2-METHOXY-3- METHYLBENZOTHIOATE.
175, d1hqeB_, 0.9447, 1.71, 0.965, 415, 397, HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
176, d1rt1B1, 0.9446, 1.45, 0.985, 406, 394, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH MKC-442
177, d4rw9B_, 0.9443, 1.69, 0.992, 405, 396, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ532) A NON- NUCLEOSIDE INHIBITOR
178, d4rw6B_, 0.9436, 1.70, 0.992, 405, 396, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH (E)-3-(3-CHLORO-5-(4-CHLORO-2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)PHENYL)ACRYLONITRILE (JLJ494) A NON-NUCLEOSIDE INHIBITOR
179, d1rt5B_, 0.9429, 1.38, 0.990, 406, 392, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC10
180, d5cymB_, 0.9427, 1.50, 0.980, 408, 393, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH 4-IODOPYRAZOLE
181, d4ko0B_, 0.9421, 1.71, 0.975, 410, 395, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH AN ANILINYLPYRIMIDINE DERIVATIVE (JLJ-135)
182, d1ep4B_, 0.9420, 1.37, 0.995, 395, 391, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH S- 1153
183, d5j1eD_, 0.9419, 1.45, 0.977, 393, 391, CRYSTAL STRUCTURE OF A HYDROXYPYRIDONE CARBOXYLIC ACID ACTIVE-SITE RNASE H INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
184, d5vqzB_, 0.9415, 1.42, 0.982, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH 2-CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
185, d3dolB_, 0.9415, 1.51, 0.985, 405, 394, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW695634.
186, d5vqwB_, 0.9414, 1.42, 0.982, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)ACRYLAMIDE (JLJ685) A NON-NUCLEOSIDE INHIBITOR
187, d5vquB_, 0.9412, 1.43, 0.982, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-2-FLUORO-N- METHYLACETAMIDE (JLJ683) A NON-NUCLEOSIDE INHIBITOR
188, d5vqvB_, 0.9410, 1.43, 0.982, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN- 1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACRYLAMIDE (JLJ684) A NON-NUCLEOSIDE INHIBITOR
189, d1klmB_, 0.9410, 1.36, 0.987, 405, 391, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH BHAP U-90152
190, d5vqyB_, 0.9406, 1.44, 0.982, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K103N Y181C) VARIANT IN COMPLEX WITH N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACRYLAMIDE (JLJ684) A NON-NUCLEOSIDE INHIBITOR
191, d5vqxB_, 0.9405, 1.44, 0.982, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (Y181C) VARIANT IN COMPLEX WITH 2-CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34- DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N- METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
192, d1jlcB_, 0.9404, 1.26, 0.982, 402, 389, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2
193, d5terB_, 0.9401, 1.46, 0.990, 401, 392, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 5- CHLORO-7-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-8-METHYL-2-NAPHTHONITRILE (JLJ651) A NON-NUCLEOSIDE INHIBITOR
194, d1s1xB1, 0.9400, 1.33, 0.987, 397, 390, CRYSTAL STRUCTURE OF V108I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
195, d1fkpB_, 0.9396, 1.28, 0.987, 408, 389, CRYSTAL STRUCTURE OF NNRTI RESISTANT K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
196, d5vqrB_, 0.9395, 1.41, 0.982, 400, 391, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACRYLAMIDE (JLJ684) A NON- NUCLEOSIDE INHIBITOR
197, d5vqqB_, 0.9392, 1.42, 0.982, 400, 391, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N-(6- CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL)ETHOXY) PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-2-FLUORO-N-METHYLACETAMIDE (JLJ683) A NON-NUCLEOSIDE INHIBITOR
198, d5vqtB_, 0.9391, 1.42, 0.982, 400, 391, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH 2- CHLORO-N-(6-CYANO-3-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL) ETHOXY)PHENOXY)-4-METHYLNAPHTHALEN-1-YL)-N-METHYLACETAMIDE (JLJ686) A NON-NUCLEOSIDE INHIBITOR
199, d3dleB_, 0.9390, 1.35, 0.990, 403, 390, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GF128590.
200, d1jlgB_, 0.9390, 1.41, 0.985, 405, 391, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH UC-781
201, d1s1vB1, 0.9383, 1.37, 0.985, 397, 390, CRYSTAL STRUCTURE OF L100I MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
202, d1jlfB_, 0.9383, 1.43, 0.985, 404, 391, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NEVIRAPINE
203, d1j5oB_, 0.9381, 2.04, 0.953, 430, 401, CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE- PRIMER
204, d5uv5D_, 0.9374, 1.38, 0.979, 393, 389, CRYSTAL STRUCTURE OF A 2-HYDROXYISOQUINOLINE-13-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE
205, d1rt4B_, 0.9374, 1.40, 0.990, 404, 390, HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH UC781
206, d1jkhB_, 0.9369, 1.35, 0.985, 398, 389, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DMP-266(EFAVIRENZ)
207, d1hmvH_, 0.9363, 1.32, 0.956, 395, 388, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
208, d1hmvF_, 0.9363, 1.32, 0.956, 395, 388, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
209, d1hmvD_, 0.9363, 1.32, 0.956, 395, 388, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
210, d1hmvB_, 0.9363, 1.32, 0.956, 395, 388, THE STRUCTURE OF UNLIGANDED REVERSE TRANSCRIPTASE FROM THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1
211, d1lweB_, 0.9357, 1.53, 0.982, 401, 392, CRYSTAL STRUCTURE OF M41L/T215Y MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMN) IN COMPLEX WITH NEVIRAPINE
212, d1hysB_, 0.9349, 1.96, 0.952, 425, 398, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA
213, d2oprB_, 0.9345, 1.34, 0.987, 400, 388, CRYSTAL STRUCTURE OF K101E MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
214, d1rt2B_, 0.9338, 1.42, 0.979, 402, 389, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH TNK-651
215, d2hmiB_, 0.9337, 2.10, 0.958, 430, 401, HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX
216, d3kjvB_, 0.9335, 1.30, 0.982, 400, 387, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA
217, d1jlaB_, 0.9335, 1.32, 0.987, 408, 387, CRYSTAL STRUCTURE OF Y181C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH TNK-651
218, d3dmjB_, 0.9325, 1.28, 0.982, 401, 386, CRYSTAL STRUCTURE OF HIV-1 V106A AND Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
219, d1tkxB1, 0.9322, 1.40, 0.987, 395, 388, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW490745
220, d5j1eB1, 0.9311, 1.62, 0.974, 404, 391, CRYSTAL STRUCTURE OF A HYDROXYPYRIDONE CARBOXYLIC ACID ACTIVE-SITE RNASE H INHIBITOR IN COMPLEX WITH HIV REVERSE TRANSCRIPTASE
221, d1lwfB_, 0.9300, 1.33, 0.982, 395, 386, CRYSTAL STRUCTURE OF A MUTANT HIV-1 REVERSE TRANSCRIPTASE (RTMQ+M184V: M41L/D67N/K70R/M184V/T215Y) IN COMPLEX WITH NEVIRAPINE
222, d2opsB_, 0.9293, 1.46, 0.987, 409, 388, CRYSTAL STRUCTURE OF Y188C MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW420867X.
223, d3dm2B_, 0.9288, 1.31, 0.987, 400, 385, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
224, d3dlgB_, 0.9275, 1.34, 0.990, 400, 385, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GW564511.
225, d5uv5B1, 0.9249, 1.50, 0.984, 399, 386, CRYSTAL STRUCTURE OF A 2-HYDROXYISOQUINOLINE-13-DIONE RNASE H ACTIVE SITE INHIBITOR WITH MULTIPLE BINDING MODES TO HIV REVERSE TRANSCRIPTASE
226, d3hvtB_, 0.9104, 1.79, 0.896, 398, 384, STRUCTURAL BASIS OF ASYMMETRY IN THE HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE HETERODIMER
227, d1mu2B_, 0.9033, 2.28, 0.584, 402, 392, CRYSTAL STRUCTURE OF HIV-2 REVERSE TRANSCRIPTASE
228, d1c0tB_, 0.8865, 1.08, 0.989, 373, 364, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH BM+21.1326
229, d4kseB_, 0.7582, 2.06, 0.962, 401, 319, CRYSTAL STRUCTURE OF A HIV P51 (219-230) DELETION MUTANT
230, p3v81B1, 0.5727, 1.07, 0.987, 241, 235, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE
231, p5xn2D1, 0.5484, 1.70, 0.965, 237, 231, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:DGTP TERNARY COMPLEX
232, p3lalB1, 0.5329, 0.45, 1.000, 216, 215, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-ETHYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
233, p3lanB1, 0.5327, 0.46, 1.000, 216, 215, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-BUTYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
234, p3lakB1, 0.5304, 0.45, 1.000, 215, 214, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-HETEROCYCLE PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
235, p3v6dD1, 0.5299, 0.88, 0.991, 222, 216, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA
236, p3lamB1, 0.5299, 0.50, 1.000, 215, 214, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH N1-PROPYL PYRIMIDINEDIONE NON-NUCLEOSIDE INHIBITOR
237, p4r5pD1, 0.5298, 0.88, 0.991, 222, 216, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND A NUCLEOSIDE TRIPHOSPHATE MIMIC ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR
238, p5vz6B1, 0.5291, 0.72, 1.000, 214, 214, HIV REVERSE TRANSCRIPTASE COMPLEXED WITH (E)-3-(PYRIMIDIN-2-YL)-N-(5- (5;6;7;8-TETRAHYDRONAPHTHALEN-2-YL)-1H-PYRAZOL-3-YL)ACRYLAMIDE 
239, p5txmD1, 0.5290, 1.01, 0.991, 222, 216, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
240, p5txlD1, 0.5290, 1.01, 0.991, 222, 216, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
241, p5hroD1, 0.5289, 1.03, 0.995, 222, 216, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND AN ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR (ALPHA-CNP)
242, p3kleJ1, 0.5288, 0.80, 0.977, 227, 215, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
243, p5txpD1, 0.5286, 1.02, 0.991, 222, 216, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
244, p5txnD1, 0.5286, 1.03, 0.991, 222, 216, STRUCTURE OF Q151M MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
245, p4q0bD1, 0.5286, 0.95, 0.995, 222, 216, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GAP- RNA/DNA AND NEVIRAPINE
246, p3v81D1, 0.5285, 0.95, 0.995, 222, 216, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND THE NONNUCLEOSIDE INHIBITOR NEVIRAPINE
247, p5txoD1, 0.5284, 1.04, 0.991, 222, 216, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
248, p5i42D1, 0.5284, 1.05, 0.995, 222, 216, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AZTTP AND CA(2+) ION
249, p3v4iD1, 0.5283, 1.05, 0.981, 222, 216, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND AZTTP
250, p3v6dB1, 0.5281, 1.10, 0.991, 222, 216, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) CROSS-LINKED WITH AZT-TERMINATED DNA
251, p3klfF1, 0.5281, 0.83, 0.995, 222, 215, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
252, p3klfB1, 0.5281, 0.83, 0.995, 222, 215, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
253, p3klhB1, 0.5278, 1.36, 0.982, 238, 218, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
254, p3kleN1, 0.5278, 0.85, 0.986, 227, 215, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
255, p5i42B1, 0.5277, 1.10, 0.995, 222, 216, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AZTTP AND CA(2+) ION
256, p5txpB1, 0.5276, 1.10, 0.995, 222, 216, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
257, p3kleF1, 0.5276, 0.86, 0.986, 227, 215, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
258, p5txoB1, 0.5275, 1.11, 0.995, 222, 216, STRUCTURE OF Q151M COMPLEX (A62V V75I F77L F116Y Q151M) MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
259, p5txnB1, 0.5275, 1.11, 0.995, 222, 216, STRUCTURE OF Q151M MUTANT HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
260, p5hroB1, 0.5275, 1.12, 0.995, 222, 216, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND AN ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR (ALPHA-CNP)
261, p4r5pB1, 0.5275, 1.12, 0.995, 222, 216, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND A NUCLEOSIDE TRIPHOSPHATE MIMIC ALPHA-CARBOXY NUCLEOSIDE PHOSPHONATE INHIBITOR
262, p3kleB1, 0.5275, 0.87, 0.986, 227, 215, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
263, p3v4iB1, 0.5274, 1.10, 0.995, 222, 216, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) WITH DNA AND AZTTP
264, p5txmB1, 0.5269, 1.14, 0.991, 221, 216, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DDATP
265, p5txlB1, 0.5269, 1.14, 0.991, 221, 216, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) TERNARY COMPLEX WITH A DOUBLE STRANDED DNA AND AN INCOMING DATP
266, p3klfN1, 0.5268, 1.05, 0.995, 223, 216, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
267, p4q0bB1, 0.5267, 1.05, 0.995, 222, 216, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH GAP- RNA/DNA AND NEVIRAPINE
268, p3jsmB1, 0.5267, 1.06, 0.991, 223, 216, K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS-DNA AND COMPLEXED WITH TENOFOVIR-DIPHOSPHATE AS THE INCOMING NUCLEOTIDE SUBSTRATE
269, p3jytB1, 0.5256, 1.11, 0.986, 223, 216, K65R MUTANT HIV-1 REVERSE TRANSCRIPTASE CROSS-LINKED TO DS- DNA AND COMPLEXED WITH DATP AS THE INCOMING NUCLEOTIDE SUBSTRATE
270, p2womB1, 0.5255, 0.79, 0.981, 221, 213, CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (K103N).
271, p3klgB1, 0.5248, 1.11, 0.995, 222, 215, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
272, p3klgF1, 0.5244, 1.12, 0.995, 222, 215, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
273, p3klfJ1, 0.5241, 1.07, 0.995, 222, 215, CRYSTAL STRUCTURE OF WILD-TYPE HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO A DSDNA WITH A BOUND EXCISION PRODUCT AZTPPPPA
274, p6bsiB1, 0.5237, 0.83, 0.991, 214, 213, STRUCTURE OF HIV-1 RT COMPLEXED WITH AN RNA/DNA HYBRID CONTAINING THE POLYPURINE-TRACT SEQUENCE
275, p4b3oB1, 0.5227, 0.87, 0.991, 216, 213, STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE
276, p5i3uB1, 0.5224, 1.30, 0.967, 226, 215, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE N-SITE COMPLEX; CATALYTIC INCORPORATION OF AZTMP TO A DNA APTAMER IN CRYSTAL
277, p5hp1B1, 0.5224, 1.31, 0.967, 226, 215, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND FOSCARNET A PYROPHOSPHATE ANALOG
278, p5hlfB1, 0.5223, 1.32, 0.972, 226, 215, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER AND AN ALPHA-CARBOXYPHOSPHONATE INHIBITOR
279, p5d3gB1, 0.5223, 1.31, 0.967, 225, 215, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A NOVEL 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER
280, p6bshB1, 0.5222, 0.52, 0.991, 214, 211, STRUCTURE OF HIV-1 RT COMPLEXED WITH RNA/DNA HYBRID IN THE RNA HYDROLYSIS MODE
281, p6bsgB1, 0.5220, 0.54, 0.991, 214, 211, STRUCTURE OF HIV-1 RT COMPLEXED WITH RNA/DNA HYBRID IN AN RNA HYDROLYSIS-OFF MODE
282, p5i3uD1, 0.5215, 1.25, 0.967, 221, 214, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE N-SITE COMPLEX; CATALYTIC INCORPORATION OF AZTMP TO A DNA APTAMER IN CRYSTAL
283, p5hp1D1, 0.5214, 1.25, 0.967, 221, 214, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A DNA APTAMER AND FOSCARNET A PYROPHOSPHATE ANALOG
284, p5d3gD1, 0.5211, 1.25, 0.972, 221, 214, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE BOUND TO A NOVEL 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER
285, p5hlfD1, 0.5202, 1.30, 0.958, 221, 214, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A 38-MER HAIRPIN TEMPLATE-PRIMER DNA APTAMER AND AN ALPHA-CARBOXYPHOSPHONATE INHIBITOR
286, p4b3qB1, 0.5201, 1.05, 0.986, 216, 213, STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE
287, p6dufB1, 0.5197, 1.59, 0.981, 221, 215, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE V106A/F227L MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
288, p6c0jB1, 0.5193, 1.70, 0.986, 224, 216, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NON- NUCLEOSIDE INHIBITOR K-5A2 
289, p6c0rB1, 0.5191, 1.63, 0.981, 221, 215, CRYSTAL STRUCTURE OF HIV-1 K103N/Y181C MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
290, p6c0lB1, 0.5191, 1.71, 0.981, 224, 216, CRYSTAL STRUCTURE OF HIV-1 E138K MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
291, p6dugB1, 0.5190, 1.56, 0.981, 221, 215, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE K101P MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
292, p6cgfB1, 0.5190, 1.72, 0.986, 224, 216, CRYSTAL STRUCTURE OF HIV-1 Y188L MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
293, p6eliB1, 0.5187, 1.33, 0.972, 226, 214, STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH RILPIVIRINE AND AN RNASE H INHIBITOR XZ462 
294, p6c0oB1, 0.5187, 1.64, 0.981, 221, 215, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
295, p6c0nB1, 0.5183, 1.65, 0.981, 221, 215, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH NON- NUCLEOSIDE INHIBITOR 25A 
296, p6c0kB1, 0.5180, 1.66, 0.977, 221, 215, CRYSTAL STRUCTURE OF HIV-1 K103N MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR K-5A2 
297, p6duhB1, 0.5174, 1.67, 0.981, 221, 215, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE Y181I MUTANT IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
298, p5c42B1, 0.5130, 0.68, 0.981, 215, 208, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (K101P) VARIANT IN COMPLEX WITH 8-(2-(2-(24-DIOXO-34-DIHYDROPYRIMIDIN-1(2H)-YL) ETHOXY)PHENOXY)INDOLIZINE-2-CARBONITRILE (JLJ555) A NON-NUCLEOSIDE INHIBITOR
299, p6bsjB1, 0.5127, 0.78, 0.981, 208, 208, STRUCTURE OF HIV-1 RT COMPLEXED WITH AN RNA/DNA HYBRID SEQUENCE NON- PREFERRED FOR RNA HYDROLYSIS
300, p5xn1B1, 0.5113, 1.51, 0.977, 218, 213, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:ENTECAVIR-TRIPHOSPHATE TERNARY COMPLEX
301, p5xn0B1, 0.5099, 1.47, 0.976, 217, 212, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA BINARY COMPLEX
302, p4b3pB1, 0.5081, 0.87, 0.990, 210, 207, STRUCTURES OF HIV-1 RT AND RNA-DNA COMPLEX REVEAL A UNIQUE RT CONFORMATION AND SUBSTRATE INTERFACE
303, p5xn2B1, 0.5079, 1.54, 0.972, 217, 212, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:DGTP TERNARY COMPLEX
304, p5xn1D1, 0.5075, 1.55, 0.958, 218, 212, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA:ENTECAVIR-TRIPHOSPHATE TERNARY COMPLEX
305, p5xn0D1, 0.5073, 1.56, 0.958, 218, 212, HIV-1 REVERSE TRANSCRIPTASE Q151M:DNA BINARY COMPLEX
306, p6c0pB1, 0.5041, 1.49, 0.976, 212, 208, CRYSTAL STRUCTURE OF HIV-1 E138K MUTANT REVERSE TRANSCRIPTASE IN COMPLEX WITH NON-NUCLEOSIDE INHIBITOR 25A 
307, p5j2nB1, 0.5014, 1.44, 0.976, 212, 208, HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DNA THAT HAS INCORPORATED EFDA-MP AT THE P-(POST-TRANSLOCATION) SITE AND DTMP AT THE N-(PRE- TRANSLOCATION) SITE
